11th Cir. Upholds Dismissal of Alcon Inc. from Glaucoma Device Case



DOCUMENTS
  • Opinion


ATLANTA — The 11th Circuit U.S. Court of Appeals has upheld dismissal of claims against Alcon Inc. filed in connection with a glaucoma device manufactured by its subsidiary Alcon Laboratories Inc., affirming that general and specific jurisdiction are lacking because Alcon Inc. is not “at home” in Alabama.

In an Aug. 31 opinion, the appellate panel also agreed with the lower court that Alcon Inc. did not inject any products in the stream of commerce in the United States.

To treat her glaucoma, Annie Parker underwent cataract surgery on Oct. 24, 2017, that also involved implanting in both eyes the …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Navigating Current Mass Tort Litigation

November 30, 2022 - New York, NY
The Knickerbocker

MORE DETAILS



HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS